A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients With Psoriasis
Clinical trial NCT06620692 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06620692
- Sponsor
- Xantho Biotechnology Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2027-12-31
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.